Prebys Center is 1 of 4 national Comprehensive Centers in the Molecular Libraries Probe Production Centers Network (MLPCN). The Network allows grantee academic institutes, non-profit organizations and small biotechnology companies access to the ultra high-throughput screening (uHTS) capabilities of Prebys Center. MLPCN also allows access to small molecules that can be used as chemical probes to study the functions of genes, cells and biochemical pathways. It will provide new ways to explore the functions of major components of cells in health and disease.
MLPCN is designed to facilitate drug development by providing early stage small molecule leads. Researchers can use these leads to validate new drug targets with the potential to move into the drug development pipeline. MLPCN holds particular promise for rare diseases which may not be attractive for private sector development.